Stock to Benefit from India’s Plan to Build 20 Nuclear...

Synopsis: MTAR Technologies manufactures precision components for India’s nuclear reactors, clean energy systems, and aerospace sector. With 20 new reactors in the pipeline and the biggest orders still to come, this stock is well worth keeping an eye on.

India is building 20 new nuclear reactors. The government has confirmed the plan. The timeline stretches over the next 5 to 8 years. And one company is already winning the orders before the tenders are even floated.

MTAR Technologies is not a new name in Indian industry. The Hyderabad-based precision manufacturer has supplied nuclear reactor components for 40 years. Its client is NPCIL, India’s state nuclear power operator. Its certifications took decades to earn. Its track record is bulletproof.

But something has shifted. India’s nuclear programme is accelerating. Clean energy demand is exploding. And MTAR finds itself at the intersection of both. The company just posted its highest-ever quarterly revenue. Its order book is at a record level. Its manufacturing plant is running at 100% capacity. And the pipeline ahead looks, by any honest measure, extraordinary. So what exactly happens to this company and this stock when 20 reactors start getting built? The numbers tell the story.

The Nuclear Pipeline

Start with the maths. MTAR already secured Rs. 500 crores worth of orders for Kaiga Units 5 and 6 just two reactors. Management has guided that each new reactor going forward will generate Rs. 350 to 400 crores of opportunity. That is up from Rs. 250 crores per reactor historically.

Apply that to India’s plan for 20 new reactors. Even if MTAR captures only 15 of them, the nuclear pipeline alone totals Rs. 5,250 crores. That is not a five-year number. That is a pipeline that starts flowing now.

Furthermore, the government is planning a dedicated PLI scheme worth Rs. 18,000 to 20,000 crores for critical nuclear component manufacturing. MTAR is the obvious beneficiary. The barriers to entry in this segment are enormous. Certifications take years. Relationships with NPCIL are irreplaceable. Competitor replication is practically impossible in any near-term window.

“Every new reactor announcement is essentially a direct order notification for MTAR before the tender is even floated.”

For FY27, management has guided Rs. 150 crores in nuclear revenue and called that figure conservative. FY28 is expected to deliver a significant further ramp. Annual order additions from the nuclear segment alone are projected at Rs. 300 to 500 crores per year. Additionally, Project ASHVINI, the government’s plan for 700 MW reactors with NTPC and NPCIL, adds another layer of structural demand. In short, India’s nuclear ambition is MTAR’s nuclear revenue. The two are inseparable.

Record Numbers and a Factory That Cannot Keep Up

The latest financial results tell a story of a company in full growth mode. In Q3 FY26, MTAR posted revenue of Rs. 278 crores. That compares with Rs. 174.5 crores in Q3 FY25 a 59.3% jump year-on-year. It was the highest quarterly revenue in the company’s history.

EBITDA nearly doubled. It rose 92.5% to Rs. 64 crores, delivering a 23% margin. Profit after tax surged 117.3% to Rs. 34.7 crores. These are not incremental improvements. These are step-change numbers.

The nine-month order book stands at Rs. 2,394.90 crores. Management is targeting Rs. 2,800 crores by the end of FY26. For FY27, the company has guided revenue growth of 50%, implying total revenues of Rs. 1,350 to 1,400 crores. EBITDA margins are expected to move significantly higher than FY26 levels, with a target of 28% by FY28.

On the other hand, the clean energy segment fuel cells supplied to American company Bloom Energy generated Rs. 387 crores in just the first nine months of FY26. It is now the single largest revenue contributor to the company. And the demand is not letting up.

Bloom Energy recently signed a $2.65 billion agreement with AEP, driven by AI data centre power demand. Bloom is projected to grow at 30% annually through 2030. MTAR is its critical manufacturing partner. As a result, MTAR is running its fuel cell plant at 100% capacity right now. The MD said it plainly on the January 2026 earnings call: ‘It’s not about orders, it’s about how much you can produce.’

The Capacity Race: From 8,000 to 30,000 Units

A manufacturer running at 100% capacity faces a rare challenge. Demand is confirmed. Customers are locked in. Revenue is directly tied to units produced. Therefore, the only constraint is the factory itself.

MTAR is addressing this with speed. Current fuel cell capacity stands at 8,000 units. Phase 1 expansion takes that to 12,000 units by March 2026. Phase 2 reaches 20,000 units by December 2026. Phase 3 targets 30,000 units by FY28. Total capex required across all three phases is approximately Rs. 90 to 100 crores a manageable number given the revenue trajectory.

The company is also moving its entire Bloom Energy operations to a new SEZ facility near the airport in Hyderabad. It is a greenfield build everything under one roof, designed specifically for long-term capacity of 30,000 units.

For investors, the three-phase expansion carries a clear message. First, every additional unit of capacity translates directly into revenue. Second, fixed costs will spread across 30,000 units instead of 8,000, structurally improving margins. Third, pricing power flows to the supplier when demand outpaces supply and at 100% utilisation, MTAR holds that power today.

The revenue maths are straightforward. The company has guided 50% revenue growth for FY27. However, if capacity ramp-up tracks to plan, FY28 could see further acceleration. The management summary table shows quarterly revenue targeting Rs. 350 crores plus in FY27, against the current Rs. 278 crores.

Aerospace, Defence and the Hidden Value Nobody Talks About

Nuclear and clean energy dominate the MTAR conversation. But the aerospace segment is quietly building into something significant and most investors have not yet priced it in.

MTAR currently produces 80 to 100 aerospace parts per month. The industry average is 300 parts per year. In other words, MTAR runs at roughly four times the pace of its peers. That execution speed matters enormously in aerospace. Faster part completion means faster customer approvals, faster certification, and faster volume production.

Key milestones are approaching rapidly. IAI first article completion is targeted for June to July 2026. Weatherford commercial operations begin in September 2026, with revenue guidance of Rs. 50 to 70 crores in FY27, scaling to Rs. 150 crores by FY28. The three-year aerospace revenue target is Rs. 350 to 400 crores from multiple customers including Boeing and Airbus via GKN and IAI.

Moreover, MTAR was declared L1 for the AMCA main landing gear test setup. The prototype value is Rs. 4 crores. However, management described the future requirement from this programme as ‘very huge.’ Defence is a long-cycle business. The seeds planted today become the revenues of the next decade.

“What you don’t see in the balance sheet is the kind of work MTAR has been doing in the background with various customers, developing various first articles, proving our capabilities.”

The full-year aerospace revenue for 9M FY26 stands at Rs. 72 crores. By FY27, management guides Rs. 150 to 160 crores. By the end of three years, the target is Rs. 350 to 400 crores. That trajectory alone would add material value to a company whose stock price today largely reflects its clean energy and nuclear segments.

The products and other segments are tracking to Rs. 130 crores for FY26 full year, adding further diversification to the revenue mix.

The MTAR Story

MTAR Technologies is not a speculative story. It is a 40-year-old precision manufacturer that built irreplaceable positions in nuclear, clean energy, and aerospace over decades of patient, technical work.

The nuclear programme is accelerating. The clean energy order book is already Rs. 1,080 crores in nine months. The aerospace segment is approaching an inflexion point. The factory is full. The expansion is underway. And the government is preparing an Rs. 18,000 to 20,000 crores PLI for the exact segment MTAR dominates.

Management said it plainly: ‘We expect to grow rapidly over the next 3 years, driven by healthy order book, favourable industrial trends and continued execution excellence.’ When India builds those 20 reactors not if, but when MTAR’s factory will be the one making the parts. That is what 40 years of irreplaceable capability looks like.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Stock to Benefit from India’s Plan to Build 20 Nuclear Reactors in the Next 5 Years appeared first on Trade Brains.